These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32429465)

  • 21. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
    Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
    J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
    Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy.
    Nöpel-Dünnebacke S; Schulmann K; Reinacher-Schick A; Porschen R; Schmiegel W; Tannapfel A; Graeven U
    Z Gastroenterol; 2014 Dec; 52(12):1394-401. PubMed ID: 25474278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new method for discovering EMAST sequences in animal models of cancer.
    Bhaskaran N; Luu J; Kelley ST; Khan MW; Mamindla P; McGuire KL
    Sci Rep; 2018 Sep; 8(1):13764. PubMed ID: 30214002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
    Catto JW; Azzouzi AR; Amira N; Rehman I; Feeley KM; Cross SS; Fromont G; Sibony M; Hamdy FC; Cussenot O; Meuth M
    Oncogene; 2003 Nov; 22(54):8699-706. PubMed ID: 14647464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.
    Garcia M; Choi C; Kim HR; Daoud Y; Toiyama Y; Takahashi M; Goel A; Boland CR; Koi M
    Gastroenterology; 2012 Jul; 143(1):48-50.e1. PubMed ID: 22465427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma.
    Mori T; Hamaya Y; Uotani T; Yamade M; Iwaizumi M; Furuta T; Miyajima H; Osawa S; Sugimoto K
    PLoS One; 2018; 13(12):e0208557. PubMed ID: 30532127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
    Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
    Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
    Hamaya Y; Guarinos C; Tseng-Rogenski SS; Iwaizumi M; Das R; Jover R; Castells A; Llor X; Andreu M; Carethers JM
    PLoS One; 2015; 10(5):e0127591. PubMed ID: 25996601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different types of microsatellite instability in ovarian carcinoma.
    Singer G; Kallinowski T; Hartmann A; Dietmaier W; Wild PJ; Schraml P; Sauter G; Mihatsch MJ; Moch H
    Int J Cancer; 2004 Nov; 112(4):643-6. PubMed ID: 15382045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability and colorectal cancer prognosis.
    Benatti P; Gafà R; Barana D; Marino M; Scarselli A; Pedroni M; Maestri I; Guerzoni L; Roncucci L; Menigatti M; Roncari B; Maffei S; Rossi G; Ponti G; Santini A; Losi L; Di Gregorio C; Oliani C; Ponz de Leon M; Lanza G
    Clin Cancer Res; 2005 Dec; 11(23):8332-40. PubMed ID: 16322293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of EMAST and microsatellite instability among patients with rectal cancer.
    Devaraj B; Lee A; Cabrera BL; Miyai K; Luo L; Ramamoorthy S; Keku T; Sandler RS; McGuire KL; Carethers JM
    J Gastrointest Surg; 2010 Oct; 14(10):1521-8. PubMed ID: 20844976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
    Antoniotti C; Borelli B; Rossini D; Pietrantonio F; Morano F; Salvatore L; Lonardi S; Marmorino F; Tamberi S; Corallo S; Tortora G; Bergamo F; Brunella DS; Boccaccino A; Grassi E; Racca P; Tamburini E; Aprile G; Moretto R; Boni L; Falcone A; Cremolini C
    BMC Cancer; 2020 Jul; 20(1):683. PubMed ID: 32698790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.
    Ulivi P; Scarpi E; Passardi A; Marisi G; Calistri D; Zoli W; Del Re M; Frassineti GL; Tassinari D; Tamberi S; Vertogen B; Amadori D
    J Transl Med; 2015 Aug; 13():258. PubMed ID: 26259598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer.
    Burger M; Burger SJ; Denzinger S; Wild PJ; Wieland WF; Blaszyk H; Obermann EC; Stoehr R; Hartmann A
    Eur Urol; 2006 Oct; 50(4):770-5; discussion 776. PubMed ID: 16762487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
    Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
    Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer.
    Watson MM; Berg M; Søreide K
    Br J Cancer; 2014 Aug; 111(5):823-7. PubMed ID: 24691426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.
    Innocenti F; Ou FS; Qu X; Zemla TJ; Niedzwiecki D; Tam R; Mahajan S; Goldberg RM; Bertagnolli MM; Blanke CD; Sanoff H; Atkins J; Polite B; Venook AP; Lenz HJ; Kabbarah O
    J Clin Oncol; 2019 May; 37(14):1217-1227. PubMed ID: 30865548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of microsatellite instability in T1 colorectal cancer.
    Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
    Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.